Simple vinegar test could rival High-Tech scope for cervical cancer screening
NCT ID NCT07692919
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study compares two ways to spot early warning signs of cervical cancer: a simple vinegar test (VIA) and a magnified exam (colposcopy). Researchers will check how well each method finds pre-cancerous changes in women aged 25 to 65 who have symptoms or abnormal Pap smears. The goal is to see if the low-cost vinegar test can be as reliable as the more expensive scope, which could make screening easier in places with fewer resources.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- acetic acid solution
- What this could lead to
- If VIA proves as accurate as colposcopy, it could offer a simpler, more accessible screening method for cervical pre-cancer in low-resource settings.
- What could go wrong
- This is a small, single-center study, and VIA may not match colposcopy's accuracy. Results may not apply broadly, and discomfort or minor complications are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Two-Pronged immune attack against HPV: could it prevent cervical cancer?
- New HPV test could save lives of women with HIV
- Could a vaginal gel replace surgery for cervical dysplasia?
- Cervical cancer screening showdown: pap vs. blood test study pulled
- New rapid test could cut antibiotic overuse for STIs